Trial intelligence / Profile preview

SALSA II: Rapid vs Slow Correction in Hypernatremia

NCT04949139Phase 4Completed

Sponsor
Seoul National University Hospital
Start
May 2021
Primary completion
Jan 2025
Countries
1
01

Overview

Phase 4, randomised, open-label trial of dextrose in hypernatremia (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Incidence of rapid change in serum sodium level within 24 hours. Started May 2021; status: completed.

02

Drugs

dextrose
03

Conditions

hypernatremia

Beyond the preview

Go deeper on NCT04949139.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04949139.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call